Introduction:
Tasigna 200 mg Capsules contain the active substance nilotinib. It is primarily prescribed to adult and pediatric patients who have recently been diagnosed with chronic myeloid leukemia and who are experiencing side effects from previous treatments.
Chronic myeloid leukemia is a type of blood cancer that causes the body to produce too many white blood cells due to changes in DNA. The aim of this treatment is to prolong survival, prevent the disease from getting worse, and ultimately reduce signs and symptoms.
Usage of Tasigna 200mg Capsule:
Pediatric and adult patients with chronic myeloid leukemia.
How Tasigna 200 mg Capsule works:
The BCR–ABL tyrosine kinase is responsible for uncontrolled cell division in CML. Tasigna 200mg Capsule disrupts the protein kinase enzyme signaling pathway. It targets the BCR-ABL protein and inhibits the growth and spread of cancer cells. It is active against mutant forms of BCR-ABL that are resistant to imatinib therapy.
Interactions with other drugs:
Tell your doctor about all medicines you are taking or have taken before treatment.
More information:
Keep it out of sight and reach of children. Do not store above 30˚C. Store in original container to protect from moisture. Do not use this medicine if the packaging is damaged.
For other medicines and pharmaceutical help checkout MrMed.
Comments